163105-90-6 Usage
Description
2-Methoxypyridine-3-boronic acid is an organic compound with the chemical formula C6H6BNO3. It is a white to light brown powder that may contain varying amounts of anhydride. 2-Methoxypyridine-3-boronic acid is characterized by the presence of a pyridine ring with a methoxy group at the 2nd position and a boronic acid group at the 3rd position.
Uses
Used in Pharmaceutical Industry:
2-Methoxypyridine-3-boronic acid is used as a building block or intermediate in the synthesis of various pharmaceutical compounds. Its unique structure allows it to be a versatile component in the development of new drugs with potential therapeutic applications.
Used in Chemical Research:
2-Methoxypyridine-3-boronic acid is also used as a research compound in various chemical studies. Its reactivity and functional groups make it a valuable tool for understanding the properties and behavior of related compounds and for exploring new chemical reactions and synthesis pathways.
Used in Material Science:
In the field of material science, 2-Methoxypyridine-3-boronic acid can be used as a precursor for the development of new materials with specific properties. Its ability to form stable complexes and coordinate with various metal ions makes it a promising candidate for the creation of advanced materials with applications in areas such as catalysis, sensors, and energy storage.
Check Digit Verification of cas no
The CAS Registry Mumber 163105-90-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,6,3,1,0 and 5 respectively; the second part has 2 digits, 9 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 163105-90:
(8*1)+(7*6)+(6*3)+(5*1)+(4*0)+(3*5)+(2*9)+(1*0)=106
106 % 10 = 6
So 163105-90-6 is a valid CAS Registry Number.
InChI:InChI=1/C6H8BNO3/c1-11-6-5(7(9)10)3-2-4-8-6/h2-4,9-10H,1H3
163105-90-6Relevant articles and documents
PIPERIDINYL-METHYL-PURINEAMINES AS NSD2 INHIBITORS AND ANTI-CANCER AGENTS
-
Page/Page column 59, (2021/02/19)
The present invention provides a compound of Formula (I): (I) or an enantiomer, an enantiomeric mixture, or a pharmaceutically acceptable salt thereof; wherein the variables are as defined herein. The present invention further provides pharmaceutical compositions comprising such compounds; and methods of using such compounds for treating a disease or condition mediated by nuclear SET domain-containing protein 2 (NSD2).
Aryl-and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine and serotonin
-
Page/Page column 17, (2008/06/13)
The present invention relates to a method of treating disorders by administering to a patient in need of such treatment a therapeutically effective amount of a compound of formula (I): wherein R1-R8 are as described herein, R4 being aryl or heteroaryl.
USING ALKYLMETAL REAGENTS FOR DIRECTED METALATION OF AZAAROMATICS
-
Page 8, (2010/02/09)
Substituted alkylmetal reagents such as (trimethylsilylmethyl)lithium are reacted with azaaromatic compounds and/or nitrogen heterocycle compounds to produce functionalized azaaromatic compounds and functionalized nitrogen heterocycle compounds.
